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and decreases expression of Toll-like receptor 4
in pulmonary artery endothelial cells exposed to
lipopolysaccharide
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John C. Densmore,5 Meetha Medhora,1,6 Elizabeth R. Jacobs1,2,3
1Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA; 2Milwaukee Initiative in Critical
Care Outcomes Research Group (MICCOR), Medical College of Wisconsin, Milwaukee, Wisconsin, USA; 3Clement J.
Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin, USA; 4Department of Biomedical Engineering,
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Abstract: Pulmonary or systemic infections and hypoxemic respiratory failure are among
the leading causes of admission to intensive care units, and these conditions frequently
exist in sequence or in tandem. Inflammatory responses to infections are reproduced by
lipopolysaccharide (LPS) engaging Toll-like receptor 4 (TLR4). Apoptosis is a hallmark of
lung injury in sepsis. This study was conducted to determine whether preexposure to LPS
or hypoxia modulated the survival of pulmonary artery endothelial cells (PAECs). We also
investigated the role TLR4 receptor expression plays in apoptosis due to these conditions.
Bovine PAECs were cultured in hypoxic or normoxic environments and treated with LPS.
TLR4 antagonist TAK-242 was used to probe the role played by TLR4 receptors in cell
survival. Cell apoptosis and survival were measured by caspase 3 activity and 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) incorporation. TLR4 expres-
sion and tumor necrosis factor α (TNF-α) production were also determined. LPS increased
caspase 3 activity in a TAK-242-sensitive manner and decreased MTT incorporation.
Apoptosis was decreased in PAECs preconditioned with hypoxia prior to LPS exposure.
LPS increased TNF-α production, and hypoxic preconditioning blunted it. Hypoxic pre-
conditioning reduced LPS-induced TLR4 messenger RNA and TLR4 protein. TAK-242
decreased to baseline the LPS-stimulated expression of TLR4 messenger RNA regardless
of environmental conditions. In contrast, LPS followed by hypoxia substantially increased
apoptosis and cell death. In conclusion, protection from LPS-stimulated PAEC apoptosis
by hypoxic preconditioning is attributable in part to reduction in TLR4 expression. If
these signaling pathways apply to septic patients, they may account for differing sensitiv-
ities of individuals to acute lung injury depending on oxygen tensions in PAECs in vivo.
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INTRODUCTION
Acute lung injury (ALI) is a common indication for
admission to the intensive care unit for both children
and adults.1 Pulmonary or systemic infections are the
leading cause of ALI. Severe sepsis and ALI are asso-
ciated with high mortality despite early and judicious
administration of antibiotic therapy.2 Novel, mecha-
nistically based strategies to prevent ALI are needed
to reduce mortality and morbidity in this condition.
Extensive studies using animal models and human
observations show that pulmonary inflammation of-
ten precedes the clinical onset and progression of
ALI3 and that these inflammatory responses persist
even after infections are controlled. Apoptosis of alve-
olar epithelial cells and pulmonary vascular endothe-
lial cells is a consistent observation in animal models
of ALI.3
Much of the inflammatory response in ALI can
be attributed to activation of the innate immune sys-
tem. Mammalian Toll-like receptors (TLRs) are part
of the innate immune system that recognizes spe-
cific patterns of microbial components that are con-
served among pathogens but that are not found
in mammals. The TLR family consists of 10 mem-
bers (TLR1–TLR10). The endotoxin lipopolysaccha-
ride (LPS), a gram-negative bacterial cell wall prod-
uct, is recognized by the TLR4 receptor, which is
critical for the initiation of a cascade of inflamma-
tory response by mammalian cells.4 TLR4 receptor
activation can lead to the induction of proinflamma-
tory genes, such as those encoding tumor necrosis
factor α (TNF-α), interleukin 6 (IL-6), and IL-2, via
activation of the transcription factor nuclear fac-
tor κB (NFκB).4,5 TAK-242 (ethyl-(6R)-[N-(2-chloro-4-
fluorophenyl]sulfamoyl]cyclohex-1-hene-1-carboxylate)
specifically inhibits TLR4 receptor–mediated signal-
ing by binding to Cys747 in the intracellular domain,
leading to suppression of the LPS-mediated inflam-
matory response.6
The expression of TLR4 on endothelial cells is
important for endotoxin-evoked infiltration of neu-
trophils into the lung tissue, increased lung mi-
crovascular permeability, and host survival.7 LPS en-
hances TLR4 expression in several cell types and
injury models.8,9 Nevertheless, there are conflict-
ing reports regarding LPS-mediated effects on TLR4
expression in pulmonary artery endothelial cells
(PAECs). For example, intratracheal administration
of LPS in mice increases the expression of TLR4 re-
ceptors on bronchial epithelial cells and macrophages
but not PAECs.9 On the other hand, intratracheal
LPS in rats is reported to decrease TLR4 messenger
RNA (mRNA) and protein in lung homogenates and
lavaged alveolar macrophages.10 Responses of endo-
thelial cells to LPS in these intact animal studies are
likely influenced by a number of variables, such as
the host immune response and release of cytokines
from other cell types in the lungs. Therefore, we ex-
amined the specific effect of LPS on TLR4 expression
in cultured PAECs.
Studies of LPS and TLR4 in a hypoxic tissue envi-
ronment, particularly in PAECs, are limited. The ef-
fect of hypoxia on LPS-mediated expression of TLR4
in lung cells has not been reported. Because hypoxia
and sepsis frequently coexist in critically ill patients,
we investigated the effect of hypoxic environment on
LPS-mediated PAEC survival and apoptosis and the
role played by TLR4 receptors in this process. We hy-
pothesized that incubation of PAECs in hypoxic con-
ditions prior to LPS exposure would diminish the
severity of LPS-mediated cell death and decrease
TLR4 expression and signaling in PAECs.
MATERIAL AND METHODS
Growth and culture of bovine PAECs (BPAECs)
Primary isolates of BPAECs were cultured at 37°C
with 5%CO2 in RPMImedium (Gibco, Carlsbad, CA)
containing 10% fetal bovine serum (Gibco) and 1%
penicillin-streptomycin (Hyclone, Logan, Utah) in a
manner reported elsewhere by us.11 When the cells
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were ∼80% confluent, they were washed twice with
phosphate-buffered saline (PBS; Gibco), and the me-
dium was changed to serum-free RPMI medium.
Cells were studied in groups as defined below.
Experimental groups
To determine the effect of hypoxia on LPS-induced
apoptosis and survival, PAECs were maintained in an
atmosphere of 95% N2 and 5% CO2 (hypoxia) or 95%
air and 5% CO2 (normoxia). The environmental oxy-
gen during hypoxia (FiO2) was continuously moni-
tored (Pro-Ox 110; Biospherix, Redfield, NY) and did
not measure above 2% at any time. Cells were washed
and then placed in medium containing LPS at 0.5–
0.75 μg/mL (derived from Escherichia coli serotype
O55:B5, source strain CDC 1644-70; Sigma, St. Louis,
MO) or vehicle andmaintained in either environment
for 24 hours.
After 24 hours, medium was replaced for the sec-
ond incubation period (with LPS or vehicle as indi-
cated in figure legends), and cells were returned to
normoxic or hypoxic environments for a second pe-
riod before assays were performed. The duration of
the second period varied on the basis of the end point
of interest (e.g., shorter for mRNA than protein) and
is defined in “Results” or in figure legends. Two pro-
tocols of hypoxia alone were tested: the first included
two periods of 24 hours each of hypoxia separated by
5–10 minutes of normoxia to exchange medium to
match the treatment protocols. The second consisted
of 48 hours of hypoxia without medium exchange.
The specific hypoxia protocol is indicated in the text
and figure legends. These exposure protocols were
chosen to optimize caspase 3 activation while limit-
ing cell detachment and death on the basis of pilot
experiments.
To determine whether the LPS effects were medi-
ated by activation of TLR4 receptors, PAECs were
preincubated with a specific TLR4 inhibitor, TAK-242
(1.0 μM; tlr-cli95; InvivoGen, San Diego, CA), before
treatment with LPS. TLR4 signaling is inhibited by
TAK-242 binding to a specific amino acid, Cys747, in
the intracellular domain of TLR4. Signaling through
TLR2, TLR35, TLR9, and TLR adapter molecules or
MD-2 (lymphocyte antigen 96) is not triggered by
TAK-242.12,13
At the end of the second treatment period, PAECs
were harvested for survival assays or for determina-
tion of TLR4 expression. For some experiments, the
cell-free medium was saved for detection of TNF-α.
For cell survival experiments, adherent cells were
washed with PBS, and the cells were scraped and
collected in 65 μL of lysis buffer (R&D Systems, Min-
neapolis, MN). The cell lysate was centrifuged at
14,000 g for 10 minutes at 4°C, and the supernatant
was collected and frozen at −80°C for determination
of caspase 3 activity. Protein concentrations were es-
timated using the BioRad Protein Dye reagent (Bio-
Rad, Hercules, CA).
Caspase 3 activity
Caspase 3 activity was determined as an apoptotic in-
dex because it represents the final common pathway
for activation of apoptosis through extrinsic and in-
trinsic mechanisms, thus measuring any caspase-
associated programmed cell death.14 The Caspase 3
Colorimetric Assay (R&D Systems) was used to deter-
mine the amount of caspase 3 activity in each sample
of cell lysates, as reported elsewhere by us.15 This
assay uses Asp-Glu-Val-Asp-pNA as a substrate for
caspase 3, with spectrophotometric detection of pur-
ple an indicator of caspase 3 activity. Caspase 3 activ-
ity was normalized for protein concentration and
reported as a percentage of caspase 3 activity in the
normoxia vehicle control.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) cell viability assay
Survival of cells was determined by MTT assay as
described in the manufacturer’s protocol (V-13154;
Molecular Probes, Eugene, OR).16 Briefly, washed cells
were incubated for 3 hours in phenol red-free me-
dium containing 0.5% of the yellow mitochondrial
dye MTT+. The amount of blue formazan dye gener-
ated fromMTT+ is proportional to the number of live
cells. The readings for the test groups of cells were ex-
pressed as percentages of normoxia vehicle control.
TNF-α production by BPAECs
A bovine TNF-α enzyme-linked immunosorbent as-
say kit (DY2279; R&D Systems) was used to deter-
mine TNF-α levels in the cell culture medium accord-
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ing to the instructions provided by the manufacturer.
Briefly, 96-well plates (DY990; R&D Systems) coated
with capture antibody and detection antibodies were
used with a streptavidin–horseradish peroxidase vi-
sualization system. TNF-α levels in cell culture me-
dium were estimated using the standard curve and
expressed as picograms per milliliter. This assay
was chosen as functional index of binding to TLR-4
receptors in our cells because it is a well-recognized
consequence of receptor engagement in endothelial
as well as other cell types.5
TLR4 mRNA expression
Expression of TLR4 mRNA was determined by real-
time polymerase chain reaction (PCR). Total RNA
was extracted by means of Trizol (Invitrogen,
Carlsbad, CA), and 1.0 μg was reverse transcribed
for first-strand complementary DNA (cDNA) synthe-
sis using Oligo(dT) primers according to the manu-
facturer’s protocol (Invitrogen). This first-strand
cDNA was then used for real-time PCR. Bovine
TLR4 (forward, ACTGCAGCTTCAACCGTATC; re-
verse, TAAAGGCTCTGCACACATCA) and glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH;
forward, TCAAGAAGGTGGTGAAGCAG; reverse,
TGTCGTACCAGGAAATGAGC) primers were con-
structed using sequences from Ibeagha-Awemu et al.17
Real-time PCR was performed with the iQ5 Multi-
color Real-Time PCR Detection System using SYBR
Green Supermix (BioRad). A two-step amplification
and thermal denaturation protocol was used for real-
time PCR. iQ5 Optical System software (ver. 2.1;
BioRad) was used to calculate the relative amounts
of genes of interest. The comparative Ct method
(2ΔΔCt) was used for quantification. This method
entails normalization of the samples with the house-
keeping gene (GAPDH) followed by comparison of
the Ct values in the samples of interest to those of
untreated controls. The results are expressed as fold
change compared with control.
TLR4 protein expression determined by Western
blot analysis
Western blots were performed on 50 μg of cell lysate
protein. Membranes were probed with anti-TLR4
(AF1478; R&D Systems) or anti-β-actin (A2228; Sigma)
antibodies. The density of bands in an image of the
Western blot was determined (ImageJ software; Na-
tional Institutes of Health), and the results were ex-
pressed as the ratio of TLR4 to β-actin.
Statistical analysis
For each assay, 3–13 separate PAEC isolates (n val-
ues) were studied. The number of replicates for each
group appears in figure legends, figures, or text. Com-
parisons between groups for all experiments were
performed using one-way analysis of variance un-
less only one treatment was studied, in which case
t tests were performed. When between-group dif-
ferences were found, a Newman-Keuls post hoc test
was employed for pairwise multiple comparisons.
Between-group and pairwise P values are provided
with symbols to indicate those that are significant.
All grouped data are presented as mean ± standard
error of the mean.
RESULTS
LPS increases apoptosis and decreases cell survival
in PAECs
Treatment with LPS for 48 hours increased caspase 3
activity (Fig. 1, left) and decreased MTT incorporation
(Fig. 1, right) in PAECs relative to vehicle controls.
Preconditioning decreases LPS-evoked stimulated
caspase 3 activity in PAECs
Next we investigated the effects of environmental
FiO2 on LPS-stimulated apoptosis. Treatment of
PAECs with LPS in normoxia for 24 or 48 hours in-
creased caspase 3 activity to values more than four
times that of cells treated with vehicle (Fig. 2; P <
0:001 relative to normoxia vehicle). Hypoxia alone
for 48 hours led to a twofold increase in caspase 3
activity compared with that of normoxic vehicle con-
trol. Preconditioning with hypoxia for 24 hours de-
creased LPS-induced increments in caspase 3 activity
compared with those of PAECs kept in normoxia for
24 hours and then treated with LPS (P < 0:025).
LPS mediates PAEC apoptosis through TLR4
receptor binding
To confirm that LPS-mediated apoptosis depends
on binding to TLR4 receptors in our PAECs, we pre-
treated cells with TAK-242 or vehicle and then mea-
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sured LPS-stimulated caspase 3 activity. TAK-242, a
specific inhibitor of the signaling mechanism acti-
vated by LPS through TLR4 engagement, abolished
LPS-mediated PAEC apoptosis (Fig. 3; P < 0:001).
Effects of hypoxic preconditioning on LPS-induced
TNF-α production
We measured LPS-stimulated TNF-α production as a
biological indicator of signaling initiated by TLR4
binding and as an index of proinflammatory re-
sponse and injury. LPS increased the expression of
TNF-α in endothelial cells grown in normoxic con-
ditions (Fig. 4). Hypoxic treatment of PAECs alone
did not affect TNF-α levels. Incubation of cells for
24 hours in hypoxia prior to treatment with LPS re-
sulted in reduction of the LPS-stimulated TNF-α lev-
els to levels not different from those of cells treated
with hypoxia and vehicle.
Effects of hypoxic preconditioning and TAK-242 on
LPS-mediated TLR4 expression
TLR4 mRNA was measured in PAECs precondi-
tioned with normoxic or hypoxic pretreatment for
24 hours followed by 4 hours of vehicle or LPS treat-
ment (Fig. 5). The effect of the TLR4 inhibitor TAK-
242 on TLR4 expression was also determined. LPS
increased TLR4 mRNA by more than eightfold com-
pared with the vehicle-treated cells kept in normoxia
(P < 0:001). Preexposure to hypoxia attenuated the
LPS-mediated increase in TLR4 expression to approx-
imately half that observed in LPS-treated cells kept
in normoxia (P < 0:001). TAK-242 decreased the
LPS-stimulated expression of TLR4 in PAECs incu-
bated in both normoxic and hypoxic conditions. Eight
hours after preconditioning with normoxia or hyp-
oxia, TLR4 protein was lower in LPS-stimulated PAECs
kept in hypoxic compared with normoxic conditions
(Fig. 6; P < 0:05).
Hypoxia after LPS worsens injury
To determine whether the order of exposure to hyp-
oxia or LPS affected injury to PAECs, caspase 3 acti-
vity and MTT were assayed in cells treated first with
LPS in normoxia for 24 hours followed by an ad-
ditional 24 hours in either normoxia or hypoxia. In
these experiments, hypoxia worsened apoptosis, as
indicated by higher caspase 3 activity and lower MTT
relative to values for cells maintained in normoxia
after LPS (Fig. 7).
DISCUSSION
LPS, the laboratory mimic of sepsis, is well recog-
nized to trigger apoptosis in endothelial cells. For ex-
ample, LPS evokes apoptosis in porcine aortic endo-
thelial cells in a concentration- and time-dependent
manner.18 Thambiayya et al.19 demonstrated that
transcellular movement of extracellular zinc and
nitric oxide contribute to LPS-induced apoptosis in
cultured sheep PAECs. However, PAECs are struc-
turally and functionally different from systemic endo-
Figure 1. Caspase 3 activity (left) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; right) were determined in pulmonary
artery endothelial cells (PAECs) incubated in normoxia and treated with vehicle or lipopolysaccharide (LPS) for 48 hours to determine the time and
concentration of maximum response. The number of experiments appears in the bars. The vehicle for LPS was physiological saline. Caspase 3
activity was increased and MTT incorporation was decreased by exposure for 48 hours to 0.5 μg/mL LPS (t tests), consistent with apoptosis and
necrosis injury of these cells. LPS-induced increments in these end points were lower in cells treated for greater or lesser time periods or with
differing concentrations of LPS.
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thelial cells, particularly with respect to native oxygen
tensions and their innate immune responses. Most
relevant to the present study, Sampath et al.20 reported
LPS-induced apoptosis and reactive oxygen species
(ROS) production in fetal ovine PAECs, which was
ameliorated by preexposure to hypoxia. Our study
shows for the first time that hypoxic precondition-
ing protects PAECs from LPS-stimulated TNF-α
production and increases in caspase 3 activity. We
also observed large LPS-induced increases in TLR4
mRNA transcripts, and these increases were blunted
by hypoxic preconditioning. These data are consis-
tent with LPS-induced upregulation of TLR4 ex-
pression in other cell types, but they are the first to
describe this upregulation in PAECs, to our knowl-
edge. We observed LPS-associated decreases TLR4
protein in the setting of increased TLR4 transcripts
in PAECs, a phenomenon previously reported in
phagocytes but not in endothelial cells. Finally, these
data are the first to identify enhanced sensitivity to
apoptosis in BPAECs treated first with LPS followed
by hypoxia.
The effect of LPS on TLR4 expression has been
studied in a variety of different models and cell types
with disparate results. Intratracheal LPS in mice
leads to increases in both mRNA and protein levels of
TLR4 in bronchial epithelial cells and alveolar macro-
phages but not in endothelial cells.9 Intratracheal LPS
in rats is reported to result in both decreases10 in
TLR4 mRNA and protein in lung homogenates and
increases21 in TLR4 mRNA in lung homogenates, ac-
companied by increased expression in endothelium
determined by immunohistochemistry. Cultured rat
lung pericytes exhibit upregulated TLR4 in response
to LPS.8 We find no previous reports of the effects of
LPS on TLR4 expression in PAECs. In human circu-
Figure 2. Caspase 3 activity was determined in pulmonary artery
endothelial cells (PAECs) incubated in hypoxia or normoxia and
treated with vehicle or lipopolysaccharide (LPS). Five groups of PAECs
were studied: (1) vehicle for 48 hours in normoxia, (2) LPS for 48
hours in normoxia, (3) vehicle alone for 48 hours in hypoxia, (4) main-
tenance in normoxia for 24 hours followed by LPS for 24 hours in
normoxia, and (5) hypoxia for 24 hours followed by LPS for 24 hours
in normoxia. P values for between-group (analysis of variance
[ANOVA]) and pairwise multiple comparisons appear in the graph.
The number of samples in each group are provided within the bars of
the figure. For all figures, the letters below the X-axis indicate the
following: N = PAECs incubated in normoxia, H = PAECs incubated
in hypoxia, V = cells treated with vehicle, LPS = cells treated with LPS,
N(V) = cells incubated in normoxia treated with vehicle, N(LPS) = cells
incubated in normoxia treated with LPS, and H(V) = cells incubated in
hypoxia treated with vehicle. ANOVA for five groups revealed between-
group differences of P < 0:001. Caspase 3 activity was increased with
all treatments compared with untreated normoxia controls and was in-
creased in PAECs kept in normoxia for 24 hours followed by LPS treat-
ment for 24 or 48 hours (*P < 0:001, bars 1 vs. 4 and bars 1 vs. 2). LPS
also increased caspase 3 activity in cells kept in hypoxic conditions prior
to treatment with LPS in normoxia (P ¼ 0:03, bars 1 vs. 5). However,
the increase was lower than that observed with cells incubated in
normoxia prior to treatment with LPS (αP < 0:025, bars 4 vs. 5). Caspase
3 activity was assessed in four additional paired samples not shown in
this graph. The first was maintained in normoxia for 24 hours, and
the second was maintained in hypoxia for 24 hours followed by 10 min-
utes of reoxygenation for exchange of medium followed by a second
24-hour period of hypoxia. The hypoxia-induced increment in caspase 3
activity in this group of cells (caspase 3 activity was 212% ± 68% of nor-
moxia control) was not different from that of cells maintained in hypoxia
for 48 hours without reoxygenation for medium change (P ¼ 0:93). Data
in the graph represent data from cells that we maintained for 48 hours
in hypoxia without medium exchange or reoxygenation.
Figure 3. Caspase 3 activity was determined in endothelial cells
incubated for 24 hours with TAK-242 or vehicle followed by treat-
ment with lipopolysaccharide (LPS) or vehicle for an additional 4 hours
(n ¼ 4 for each group). The vehicle for TAK-242 was dimethyl sulfox-
ide diluted 1 ∶ 1,000 with phosphate-buffered saline. LPS-mediated ap-
optosis was reduced to baseline in cells treated with TAK-242 (P < 0:001).
TAK-242 treatment by itself did not affect apoptosis relative to vehicle
control (bar 3). n values appear in the bars. ANOVA: analysis of variance.
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lating mononuclear phagocytes, LPS increases TLR4
mRNA but decreases the surface expression of these
receptors, similar to our observations in cultured
PAECs.22 The authors hypothesize that the increase
in TLR4 mRNA by LPS counters the reduction of sur-
face expression. LPS binding to TLR4 surface recep-
tors initiates internalization and destruction of these
proteins. The rate of loss of these receptors exceeds
the rate for replenishment; therefore, there is a net
reduction in the steady-state surface expression of
these receptors.22 Our findings show that LPS stimu-
lated the TLR4 transcript in PAECs and that this in-
crease was blunted in cells pretreated with hypoxia.
Similarly, TLR4 protein density was higher in LPS-
treated PAECs kept in normoxic relative to hypoxic
conditions (Fig. 7). Functional implications of changes
in TLR4 expression should be more closely linked
to protein density rather than transcript numbers.
Thus, our observations are consistent with the data
in phagocytes,22 although though new for PAECs.
They support the hypothesis that (i) hypoxic precon-
ditioning protects from LPS partially through de-
creased expression of TLR4 and (ii) LPS stimulation
of TLR4 transcripts could be instrumental in the
maintenance receptor density in PAECs. Neverthe-
less, direct investigations of the role played by LPS
in internalization or destruction of TLR4 receptors
and the time frame over which this occurs in PAECs
remain to be undertaken.
Seki et al.23 and Sha et al.24 have reported that inhi-
bition of TLR4 with TAK-242 protects mice from LPS-
induced increases in pulmonary polymorphonuclear
leukocyte infiltration, increased microvascular per-
meability, and cytokine release into the bronchoalveo-
lar lavage and that it increases survival. Our studies
show that TAK-242 not only decreases PAEC apopto-
sis but also decreases LPS-stimulated TLR4 mRNA.
These data add further support to the hypothesis
that increments of TLR4 mRNA may be necessary
for the full activation of the inflammatory pathway
by LPS in PAECs.
Figure 4. Tumor necrosis factor α (TNF-α) induction by lipopolysac-
charide (LPS) is blunted by hypoxia preconditioning. Pulmonary artery
endothelial cells (PAECs) were cultured in conditions of normoxia or
hypoxia for 24 hours followed by normoxia with vehicle or LPS for an
additional 24 hours (n ¼ 4 for all groups). LPS increases the expression
of TNF-α in endothelial cells kept in normoxic conditions (P < 0:025).
Pretreatment with hypoxia for 24 hours prior to LPS leads to reduced
LPS-mediated TNF-α levels (P < 0:025). ANOVA: analysis of variance.
Figure 5. Toll-like receptor 4 (TLR4) expression in pulmonary ar-
tery endothelial cells (PAECs) preconditioned in hypoxia and treated
with lipopolysaccharide (LPS) and TAK-242. Preliminary experiments
showed that LPS-stimulated expression of TLR4 messenger RNA (mRNA)
peaked 4 hours after exposure followed by a decrease to basal levels at
24 hours (not shown). Accordingly, PAECs were incubated in conditions
of hypoxia or normoxia for 24 hours followed by treatment with LPS or
vehicle for an additional 4 hours, and then TLR4 mRNA was measured
(n ¼ 4 for all groups). LPS increases the expression of TLR4 several-
fold compared with untreated cells (P < 0:001, bars 1 vs. 2). A t test of
TLR4 mRNA from cells treated with hypoxia alone compared with norm-
oxia (bars 1 vs. 5) revealed a hypoxia-induced decrease in TLR4 (P < 0:05).
Preconditioning of the cells in hypoxia prior to treatment with LPS leads
to a reduction in TLR4 expression (P < 0:001, bars 2 vs. 6). The effect of
TAK-242 on LPS-stimulated TLR4 mRNA expression was determined
by incubating PAECs in hypoxic or normoxic conditions for 24 hours
with TAK-242 or vehicle followed by treatment with LPS or vehicle for
an additional 4 hours (n ¼ 4 separate isolates of PAECs). TAK-242 de-
creased the expression of LPS-stimulated TLR4 cells incubated in both
normoxic and hypoxic conditions (P < 0:001, analysis of variance [ANOVA];
other pairwise comparisons are as per the graph).
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We found increases in TNF-α in PAECs treated
with LPS, verifying an inflammatory response initi-
ated by binding to TLR4 receptors in our BPAECs, as
has been reported in a number of cell types.25,26 Acti-
vation of TLR4 induces inflammatory responses by
initiating multiple intracellular signaling events, in-
cluding the activation of NFκB, which initiates syn-
thesis and release of many proinflammatory medi-
ators and adhesion molecules, such as IL-1, IL-6,
IL-8, TNF-α, and intercellular adhesion molecule 1
(ICAM-1). These signaling pathways have been veri-
fied in PAECs.25 Furthermore, TNF-α causes apopto-
sis in PAECs, liver endothelial cells, and bovine aorta
endothelial cells in culture.27-29 Since TLR4 recep-
tors are preferentially utilized by LPS for the induc-
tion of the inflammatory pathway,5,30 a reduction in
these receptors could lead to a reduction in the LPS-
stimulated activation of the inflammatory pathway.
Some of these inflammatory pathwaysmay be related
to the increased sensitivity of BPAECs to hypoxia-
induced apoptosis after treatment with LPS, but our
data do not permit us to address this question.
We are keenly interested in the mechanisms
through which hypoxic exposure may be protective
from subsequent exposure to LPS. Perhaps the best-
recognized signaling pathway by hypoxia and an-
oxia is hypoxia inducible factor 1α (HIF-1α). Hypoxia
triggers decreased degradation, nuclear translocation,
and binding of HIF-1α to hypoxia-response elements.
Induction of HIF-1α protein and its transcriptional
activation by hypoxia and oxidative stress are also reg-
ulated by signaling pathways, including PI3K/AKT/
FRAP30–32, p38, and extracellular signal-regulated
protein kinase.31-33 Redox-sensitive factors Ref-1 and
thioredoxin and the Rho family small GTPase Rac1
have been shown to play a role.32-34 Enhanced nitric
Figure 6. Effect of lipopolysaccharide (LPS) on Toll-like receptor 4
(TLR4) protein in pulmonary artery endothelial cells (PAECs). Cells
were treated with LPS or vehicle for 8 hours. In data not shown, hyp-
oxia alone had no effect on TLR4 protein relative to PAECs in
normoxia. Eight hours after LPS treatment, TLR4 protein in PAECs
preconditioned with hypoxia was less than that observed in the cells
kept in normoxic environment. n values appear in the bars, and P
values with symbols appear within the graphs.
Figure 7. Hypoxia after lipopolysaccharide (LPS) exacerbates injury. Pulmonary artery endothelial cells (PAECs) were treated with 0.5 μg/mL
LPS for 24 hours in a normoxic environment, after which time the medium was exchanged for LPS-free medium. Cells were then maintained
another 24 hours in either normoxia or hypoxia, after which time caspase 3 activity (left) or 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT; right) was measured. Relative to cells maintained in normoxia after LPS treatment, caspase 3 activity was increased and MTT was
decreased in PAECs kept in a hypoxic environment. n values appear in the bars, and P values with symbols appear within the graphs.
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oxide release and activation of Bcl-2 are other prosur-
vival pathways activated by hypoxia.35 Protection
from oxidative stress–induced apoptosis in cortical
neuronal cultures by iron chelators correlates to en-
hanced DNA binding of HIF-1α and ATF-1/CREB
transcription factors and to increased expression of
glycolytic enzymes.34 HIF-1α can mediate crosstalk
between hypoxia and glucose metabolism via glucose-
response elements.36 Our experiments show that hyp-
oxia in PAECs blocks LPS-induced increments in
TNF-α, suggesting that one pathway of protection
from apoptosis by hypoxic preconditioning may be
through attenuated synthesis and release of this cy-
tokine involving one or more of the above-described
signaling cascades.
Some studies suggest that hypoxia-induced modu-
lation of TLR4 expression may be critical to the LPS-
mediated inflammatory pathways in nonpulmonary
cells.26,37 Hara et al.26 reported that hypoxia reduces
TLR4 mRNA in immortalized and cultured corneal
epithelial cells, leading to a reduction in NFκB activa-
tion with concomitant reduction in IL-6 and IL-8. Ock
et al.37 reported that hypoxia results in upregulation
of TLR4 expression and enhanced myeloid differenti-
ation factor 88–independent interferon regulatory fac-
tor 3 pathway but, interestingly, a decrease in LPS-
induced NFκB in microglial cells. Leeper-Woodford
and Detmer38 observed that acute hypoxia enhances
LPS-stimulated cytokine production by greater acti-
vation of NFκB in alveolar macrophages. Sampath
et al.,20 on the other hand, reported that preexposure
to hypoxia (FiO2 of 0.05 for 24–48 hours) decreases
LPS-induced apoptosis and ROS production in fetal
ovine PAECs. The study of Sampath et al. did not
include investigations of TLR4 receptor expression.
In data not shown, we measured LPS-induced incre-
ments in dihydroethidium (a fluorescent marker of
ROS, particularly superoxide) in BPAECsmaintained
in normoxia. We found modest time-dependent in-
crements in LPS-induced dihydroethidium fluores-
cence peaking at 6 hours after exposure, confirming
a qualitatively similar response in bovine as in ovine
PAECs. Ishida et al.39 demonstrated that hypoxia de-
creased TLR4 protein and mRNA expression in hu-
man PAECs in a manner that depends on mitochon-
drial ROS. Furthermore, LPS-induced increments in
ICAM expression were decreased by hypoxia, suggest-
ing to them that hypoxia-induced downregulation
of TLR4 alters cellular responsiveness to endotoxin.
Cell survival or apoptosis were not evaluated as an
end point in the study of Ishida et al. The role played
by mitochondrial ROS in modifying TLR4 expres-
sion in hypoxia preconditioning or the mechanisms
underlying worsened injury in PAECs exposed to hyp-
oxia after LPS are very interesting questions for fu-
ture studies.
Both sepsis and hypoxia are common conditions in
intensive care units and in fact often coexist in the
same patient, either simultaneously or in series. Little
information has been available regarding the interac-
tion of these conditions or the mechanism through
which one may modulate the effect of the other. Our
observations that LPS- and TLR4-mediated induction
of the inflammatory pathway and apoptosis can be
modulated by preexposure to hypoxia suggest that a
hypoxic environment (e.g., in an area of atelectasis)
may limit escalation of an inflammatory response in
an injured lung. Because apoptosis is enhanced and
survival decreased in PAECs first stressed with LPS
and then exposed to hypoxia, individuals with sub-
clinical sepsis suffering subsequent insults causing
hypoxia may be at risk of particularly severe lung in-
jury. We have previously reported that TLR4 expres-
sion is increased in ischemic lung injury in vivo.40
However, the role played by lung preexposure to hyp-
oxia or LPS in vivo remains to be tested.
ACKNOWLEDGMENTS
We appreciate the expert technical assistance of Stepha-
nie Gruenloh and Ying Gao in cell culturing and assays.
REFERENCES
1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin
DP, Neff M, et al. Incidence and outcomes of acute lung
injury. N Engl J Med 2005;353(16):1685–1693.
2. Irish Critical Care Trials Group. Acute lung injury and the
acute respiratory distress syndrome in Ireland: a prospective
audit of epidemiology and management. Crit Care 2008;12
(1):R30.
3. Matute-Bello G, Frevert CW, Martin TR. Animal models of
acute lung injury. Am J Physiol Lung Cell Mol Physiol
2008;295(3):L379–L399.
4. Takeda K, Akira S. TLR signaling pathways. Semin Immu-
nol 2004;16(1):3–9.
5. Dauphinee SM, Karsan A. Lipopolysaccharide signaling in
endothelial cells. Lab Invest 2006;86(1):9–22.
586 | Hypoxia preconditioning and LPS in PAECs Ali et al.
6. Wittebole X, Castanares-Zapatero D, Laterre PF. Toll-like re-
ceptor 4 modulation as a strategy to treat sepsis. Mediators In-
flamm 2010;2010:568396.
7. Andonegui G, Bonder CS, Green F, Mullaly SC, Zbytnuik L,
Raharjo E, et al. Endothelium-derived Toll-like receptor–4 is
the key molecule in LPS-induced neutrophil sequestration
into lungs. J Clin Invest 2003;111(7):1011–1020.
8. Edelman DA, Jiang Y, Tyburski J, Wilson RF, Steffes C. Toll-
like receptor–4 message is up-regulated in lipopolysaccharide-
exposed rat lung pericytes. J Surg Res 2006;134(1):22–27.
9. Saito T, Yamamoto T, Kazawa T, Gejyo H, Naito M. Expres-
sion of Toll-like receptor 2 and 4 in lipopolysaccharide-
induced lung injury in mouse. Cell Tissue Res 2005;321(1):
75–88.
10. Fan J, Kapus A, Marsden PA, Li YH, Oreopoulos G, Mar-
shall JC, et al. Regulation of Toll-like receptor 4 expression
in the lung following hemorrhagic shock and lipopolysac-
charide. J Immunol 2002;168(10):5252–5259.
11. Medhora M, Chen Y, Gruenloh S, Harland D, Bodiga S,
Zielonka J, et al. 20-HETE increases superoxide production
and activates NAPDH oxidase in pulmonary artery endothe-
lial cells. Am J Physiol Lung Cell Mol Physiol 2008;294(5):
L902–L911.
12. Takashima K, Matsunaga N, Yoshimatsu M, Hazeki K,
Kaisho T, Uekata M, Hazeki O, Akira S, Iizawa Y, Ii M. An-
alysis of binding site for the novel small-molecule TLR4
signal transduction inhibitor TAK-242 and its therapeutic ef-
fect on mouse sepsis model. Br J Pharmacol 2009;157(7):
1250–1262.
13. Kawamoto T, Ii M, Kitazaki T, Iizawa Y, Kimura H. TAK-
242 selectively suppresses Toll-like receptor 4-signaling med-
iated by the intracellular domain. Eur J Pharmacol 2008;584
(1):40–48.
14. Favaloro B, Allocati N, Graziano V, Di Ilio C, De Laurenzi
V. Role of apoptosis in disease. Aging (Albany NY) 2012;4
(5):330–349.
15. Dhanasekaran A, Bodiga S, Gruenloh S, Gao Y, Dunn L,
Falck JR, et al. 20-HETE increases survival and decreases
apoptosis in pulmonary arteries and pulmonary artery endo-
thelial cells. Am J Physiol Heart Circ Physiol 2009;296(3):
H777–H786.
16. Dhanasekaran A, Gruenloh SK, Buonaccorsi JN, Zhang R,
Gross GJ, Falck JR, et al. Multiple antiapoptotic targets of the
PI3K/Akt survival pathway are activated by epoxyeicosatrie-
noic acids to protect cardiomyocytes from hypoxia/anoxia.
Am J Physiol Heart Circ Physiol 2008;294(2):H724–H735.
17. Ibeagha-Awemu EM, Lee JW, Ibeagha AE, Bannerman
DD, Paape MJ, Zhao X. Bacterial lipopolysaccharide induces
increased expression of toll-like receptor (TLR) 4 and down-
stream TLR signaling molecules in bovine mammary epi-
thelial cells. Vet Res 2008;39(2):11.
18. Bernardini C, Zannoni A, Turba ME, Fantinati P,
Tamanini C, Bacci ML, Forni M. Heat shock protein 70,
heat shock protein 32, and vascular endothelial growth fac-
tor production and their effects on lipopolysaccharide-induced
apoptosis in porcine aortic endothelial cells. Cell Stress Chap-
erones 2005;10(4):340–348.
19. Thambiayya K, Wasserloos KJ, Huang Z, Kagan VE, St.
Croix CM, Pitt BR. PS-induced decrease in intracellular la-
bile zinc, [Zn]i, contributes to apoptosis in cultured sheep
pulmonary artery endothelial cells. Am J Physiol Lung Cell
Mol Physiol 2011;300(4):L624–L632.
20. Sampath V, Radish AC, Eis AL, Broniowska K, Hogg N,
Konduri GG. Attenuation of lipopolysaccharide-induced oxi-
dative stress and apoptosis in fetal pulmonary artery endo-
thelial cells by hypoxia. Free Radic Biol Med 2009;46(5):
663–671.
21. Janardhan KS, McIsaac M, Fowlie J, Shrivastav A, Caldwell
S, Sharma RK, et al. Toll like receptor–4 expression in lipo-
polysaccharide induced lung inflammation. Histol Histopa-
thol 2006;21(7):687–696.
22. Bosisio D, Polentarutti N, Sironi M, Bernasconi S, Miyake
K, Webb GR, et al. Stimulation of toll-like receptor 4 expres-
sion in human mononuclear phagocytes by interferon-γ: a
molecular basis for priming and synergism with bacterial li-
popolysaccharide. Blood 2002;99(9):3427–3431.
23. Seki H, Tasaka S, Fukunaga K, Shiraishi Y, Moriyama K,
Miyamoto K, et al. Effect of Toll-like receptor 4 inhibitor on
LPS-induced lung injury. Inflamm Res 2010;59(10):837–845.
24. Sha T, Sunamoto M, Kitazaki T, Sato J, Ii M, Iizawa Y.
Therapeutic effects of TAK-242, a novel selective Toll-like
receptor 4 signal transduction inhibitor, in mouse endotoxin
shock model. Eur J Pharmacol 2007;571(2–3):231–239.
25. Cendan JC, Moldawer LL, Souba WW, Copeland EM III,
Lind DS. Endotoxin-induced nitric oxide production in pul-
monary artery endothelial cells is regulated by cytokines.
Arch Surg 1994;129(12):1296–1300.
26. Hara Y, Shiraishi A, Ohashi Y. Hypoxia-altered signaling
pathways of toll-like receptor 4 (TLR4) in human corneal
epithelial cells. Mol Vis 2009;15:2515–2520.
27. Marino E, Cardier JE. Differential effect of IL-18 on endo-
thelial cell apoptosis mediated by TNF-α and Fas (CD95).
Cytokine 2003;22(5):142–148.
28. Robaye B, Mosselmans R, Fiers W, Dumont JE, Galand P.
Tumor necrosis factor induces apoptosis (programmed cell
death) in normal endothelial cells in vitro. Am J Pathol 1991;
138(2):447–453.
29. Wendt CH, Polunovsky VA, Peterson MS, Bitterman PB,
Ingbar DH. Alveolar epithelial cells regulate the induction
of endothelial cell apoptosis. Am J Physiol 1994;267(4 pt 1):
C893–C900.
30. Casanova JL, Abel L, Quintana-Murci L. Human TLRs and
IL-1Rs in host defense: natural insights from evolutionary,
epidemiological, and clinical genetics. Annu Rev Immunol
2011;29:447–491.
31. Yu EZ, Li YY, Liu XH, Kagan E, McCarron RM. Anti-
apoptotic action of hypoxia-inducible factor–1α in human en-
dothelial cells. Lab Invest 2004;84(5):553–561.
32. Welsh SJ, Williams RR, Birmingham A, et al. The
thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl di-
Pulmonary Circulation Volume 3 Number 3 September 2013 | 587
sulfide and pleurotin inhibit hypoxia-induced factor 1α and
vascular endothelial growth factor formation. Mol Cancer
Ther 2003;2:235–243.
33. Semenza G. Signal transduction to hypoxia-inducible factor
1. Biochem Pharmacol 2002;64:993–998.
34. Wang N, Stemerman MB. Ref-1 and transcriptional control
of endothelial apoptosis. Circ Res 2001;88:1223–1225.
35. Marzo F, Lavorgna A, Coluzzi G, Santucci E, Tarantino F,
Rio T, Conti E, Autore C, Agati L, Andreotti F. Erythropoie-
tin in heart and vessels: focus on transcription and signal-
ling pathways. J Thromb Thrombolysis 2008;26(3):183–187.
36. Kietzmann T, Krones-Herzig A, Jungermann K. Signaling
cross-talk between hypoxia and glucose via hypoxia-inducible
factor 1 and glucose response elements. Biochem Pharma-
col 2002;64:903–911.
37. Ock J, Jeong J, Choi WS, Lee WH, Kim SH, Kim IK, et al.
Regulation of Toll-like receptor 4 expression and its signal-
ing by hypoxia in cultured microglia. J Neurosci Res 2007;
85(9):1989–1995.
38. Leeper-Woodford SK, Detmer K. Acute hypoxia increases
alveolar macrophage tumor necrosis factor activity and alters
NF-κB expression. Am J Physiol 1999;276(6 pt 1):L909–L916.
39. Ishida I, Kubo H, Suzuki S, Suzuki T, Akashi S, Inoue K,
Maeda S, Kikuchi J, Sasaki H, Kondo T. Hypoxia dimin-
ishes toll-like-receptor 4 expression through reactive oxygen
species generated by mitochondria in endothelial cells. J Im-
munol 2002;169(4):2069–2075.
40. Ali I, Gruenloh S, Gao Y, Clough A, Falck JR, Medhora M,
Jacobs ER. Protection by 20-5,14-HEDGE against surgically
induced ischemia reperfusion lung injury in rats. Ann Thorac
Surg 2012;93(1):282–288.
Source of Support: National Heart, Lung, and Blood Institute: HL-
68627, HL-49294, HL-116530, and BX001681 to ERJ; UL1RR031973 to
GGK and ERJ; and 8UL1TR000055 to SA.
Conflict of Interest: None declared.
588 | Hypoxia preconditioning and LPS in PAECs Ali et al.
